Moore Capital Management, LP Royalty Pharma PLC Transaction History
Moore Capital Management, LP
- $5.98 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
394Shares Held
278MCall Options Held
276KPut Options Held
236K-
Morgan Stanley New York, NY44.2MShares$1.24 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.7MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$597 Million0.02% of portfolio
-
Baillie Gifford & CO16.7MShares$469 Million0.4% of portfolio
-
Viking Global Investors LP11.5MShares$323 Million1.33% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...